Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.
作者:
主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗体, 单克隆, 鼠源性(Antibodies, Monoclonal, Murine-Derived);抗肿瘤药(Antineoplastic Agents);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);环磷酰胺(Cyclophosphamide);多柔比星(Doxorubicin);女(雌)性(Female);人类(Humans);白细胞计数(Leukocyte Count);淋巴细胞(Lymphocytes);淋巴瘤, 滤泡性(Lymphoma, Follicular);淋巴瘤, 大B细胞, 弥漫性(Lymphoma, Large B-Cell, Diffuse);男(雄)性(Male);中年人(Middle Aged);单核细胞(Monocytes);肿瘤分期(Neoplasm Staging);泼尼松(Prednisone);预后(Prognosis);回顾性研究(Retrospective Studies);存活率分析(Survival Analysis);治疗结果(Treatment Outcome);长春新碱(Vincristine);青年人(Young Adult)
DOI
10.1016/j.clml.2014.10.001
PMID
25468321
发布时间
2015-03-27
- 浏览94
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文